SchizophreniaNCT07365982
Effect of Psychoeducation -Based Motivational Interviewing on Knowledge and Hope in Schizophrenia
A study testing Psychoeducation-Based Motivational Interviewing in people with Schizophrenia, run by Büşra Taşkıner at 1 site in Turkey (Türkiye).
Trial summary
This study aimed to examine the effect of a psychoeducation-based motivational interviewing intervention on schizophrenia-related knowledge and hope levels among patients diagnosed with schizophrenia. Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Schizophrenia
- What is being tested?
- Psychoeducation-Based Motivational Interviewing
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 44 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 21 Apr 2025to 30 Jun 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Volunteered to participate in the study and provided informed consent
- Aged between 18 and 65 years
- Literate
- Diagnosed with schizophrenia according to DSM-5 diagnostic criteria
- In remission phase (not in an acute exacerbation period)
Who cannot join
- Presence of severe intellectual disability as documented in hospital records
- Diagnosis of dementia and/or other organic mental disorders
- Currently in an acute exacerbation phase
- Discontinuation of intervention sessions or failure to complete assessment forms
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Zeytinburnu Community Mental Health Center (TRSM)
Istanbul
About this study
Official title: THE EFFECT OF PSYCHOEDUCATION-BASED MOTIVATIONAL INTERVIEWING ON KNOWLEDGE ABOUT SCHIZOPHRENIA AND HOPE LEVELS IN PATIENTS DIAGNOSED WITH SCHIZOPHRENIA
This study aimed to examine the effect of a psychoeducation-based motivational interviewing intervention on schizophrenia-related knowledge and hope levels among patients diagnosed with schizophrenia. The study employed a randomized controlled experimental design with pre-test, post-test, and one-month follow-up measurements. Participants were recruited from a community mental health center and assigned to an intervention group or a control group. The intervention group participated in a structured psychoeducation-based motivational interviewing program consisting of one preparatory session followed by five main sessions, while the control group continued to receive routine community mental health services. Knowledge about schizophrenia and hope levels were assessed using validated measurement tools.
Read the detailed description
The present study aimed to examine the effect of a psychoeducation-based motivational interviewing intervention on schizophrenia-related knowledge and hope levels among patients diagnosed with schizophrenia. The study was conducted using a randomized controlled experimental design with pre-test, post-test, and one-month follow-up measurements.
A total of 44 patients diagnosed with schizophrenia were included in the study, with 21 participants assigned to the intervention group and 23 to the control group. The study was carried out with individuals followed at a community mental health center between January and June 2025.
Participants in the intervention group received a structured psychoeducation-based motivational interviewing program consisting of one preparatory session followed by five main sessions. The sessions were conducted at least once per week, and each session lasted approximately 60 to 90 minutes. Throughout the study period, the control group continued to receive routine community mental health services.
Data were collected using a Demographic Information Form, the Schizophrenia Knowledge Level Scale, and the Schizophrenia Hope Scale. Changes in knowledge and hope levels were evaluated across measurement points.
- Conditions
- Schizophrenia
- Being tested
- Psychoeducation-Based Motivational Interviewing
- Keywords
- Schizophrenia, Psychoeducation, Motivational Interviewing, Knowledge Level, Hope
- Medical subject headings
- Schizophrenia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Psychoeducation-Based Motivational InterviewingBehavioural
A structured psychoeducation-based motivational interviewing program delivered in weekly sessions lasting approximately 60-90 minutes, consisting of one preparatory session followed by five main sessions.
| Study group | Role | What they receive |
|---|---|---|
| Psychoeducation-Based Motivational Interviewing | Experimental | Participants received a psychoeducation-based motivational interviewing program consisting of one preparatory session followed by five main sessions, in addition to routine community mental health services. Receives: Behavioral: Psychoeducation-Based Motivational Interviewing |
| Control Group - Routine Community Mental Health Services | No intervention | Participants received routine community mental health center services only, without any additional psychosocial or motivational interviewing intervention. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Schizophrenia Knowledge Level
Change in schizophrenia-related knowledge level assessed using the Schizophrenia Knowledge Level Scale. The scale consists of multiple-choice items assessing knowledge about schizophrenia, with total scores ranging from 0 to 25. Higher scores indicate greater knowledge about schizophrenia.
Measured: Baseline (pre-test) prior to the intervention, immediately after completion of the final intervention session (post-test), and 1 month after completion of the intervention (follow-up assessment).
Secondary outcomes (1)
Schizophrenia Hope Level
Change in hope level assessed using the Schizophrenia Hope Scale. The scale is a Likert-type measure with total scores ranging from 0 to 18. Higher scores indicate higher levels of hope.
Measured: Baseline (pre-test) prior to the intervention, immediately after completion of the final intervention session (post-test), and 1 month after completion of the intervention (follow-up assessment).
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Jan 2026
- Study start21 Apr 2025
- Primary completion30 Jun 2025
- Study completion30 Jun 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for SchizophreniaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Participants were randomly assigned to either an intervention group or a control group and followed in parallel throughout the study period.
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 44 participants (actual)
Sponsor and investigators
- Lead sponsor
- Büşra Taşkıner
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Büşra Taşkıner, Okan University
- Investigators
- Ceren Aycanoğlu, Assoc. Prof. Dr., Principal investigator, Okan University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07365982
- Sponsor's protocol ID
- OKAN-ETIK-2025-K8
- Status last verified
- Jan 2026
- First submitted
- 9 Jan 2026
- Last updated
- 26 Jan 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data will not be shared, as the study is conducted as part of a master's thesis and the data are collected solely for academic purposes. All data are kept confidential in accordance with ethical approval and institutional regulations.
Study at a glance
From the registry record, last updated by the sponsor on 26 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- THE EFFECT OF PSYCHOEDUCATION-BASED MOTIVATIONAL INTERVIEWING ON KNOWLEDGE ABOUT SCHIZOPHRENIA AND HOPE LEVELS IN PATIENTS DIAGNOSED WITH SCHIZOPHRENIA
- ClinicalTrials.gov ID
- NCT07365982
- Acronym / sponsor ID
- OKAN-ETIK-2025-K8
- Conditions
- Schizophrenia
- Keywords
- Schizophrenia, Psychoeducation, Motivational Interviewing, Knowledge Level, Hope
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 44 participants (actual)
- Lead sponsor
- Büşra TaşkınerUniversity, hospital or other
- Study start
- 21 Apr 2025 (actual)
- Primary completion
- 30 Jun 2025 (actual)
- Study completion
- 30 Jun 2025 (actual)
- First posted
- 26 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aimed to examine the effect of a psychoeducation-based motivational interviewing intervention on schizophrenia-related knowledge and hope levels among patients diagnosed with schizophrenia. The study employed a randomized controlled experimental design with pre-test, post-test, and one-month follow-up measurements. Participants were recruited from a community mental health center and assigned to an intervention group or a control group. The intervention group participated in a structured psychoeducation-based motivational interviewing program consisting of one preparatory session followed by five main sessions, while the control group continued to receive routine community mental health services. Knowledge about schizophrenia and hope levels were assessed using validated measurement tools.
Detailed description
The present study aimed to examine the effect of a psychoeducation-based motivational interviewing intervention on schizophrenia-related knowledge and hope levels among patients diagnosed with schizophrenia. The study was conducted using a randomized controlled experimental design with pre-test, post-test, and one-month follow-up measurements.
A total of 44 patients diagnosed with schizophrenia were included in the study, with 21 participants assigned to the intervention group and 23 to the control group. The study was carried out with individuals followed at a community mental health center between January and June 2025.
Participants in the intervention group received a structured psychoeducation-based motivational interviewing program consisting of one preparatory session followed by five main sessions. The sessions were conducted at least once per week, and each session lasted approximately 60 to 90 minutes. Throughout the study period, the control group continued to receive routine community mental health services.
Data were collected using a Demographic Information Form, the Schizophrenia Knowledge Level Scale, and the Schizophrenia Hope Scale. Changes in knowledge and hope levels were evaluated across measurement points.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
- Model description
- Participants were randomly assigned to either an intervention group or a control group and followed in parallel throughout the study period.
| Arm | Type | Receives |
|---|---|---|
| Psychoeducation-Based Motivational Interviewing | Experimental | Behavioral: Psychoeducation-Based Motivational InterviewingParticipants received a psychoeducation-based motivational interviewing program consisting of one preparatory session followed by five main sessions, in addition to routine community mental health services. |
| Control Group - Routine Community Mental Health Services | No intervention | –Participants received routine community mental health center services only, without any additional psychosocial or motivational interviewing intervention. |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Volunteered to participate in the study and provided informed consent
- Aged between 18 and 65 years
- Literate
- Diagnosed with schizophrenia according to DSM-5 diagnostic criteria
- In remission phase (not in an acute exacerbation period)
Key exclusion criteria (4 listed)
- Presence of severe intellectual disability as documented in hospital records
- Diagnosis of dementia and/or other organic mental disorders
- Currently in an acute exacerbation phase
- Discontinuation of intervention sessions or failure to complete assessment forms
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Psychoeducation-Based Motivational InterviewingA structured psychoeducation-based motivational interviewing program delivered in weekly sessions lasting approximately 60-90 minutes, consisting of one preparatory session followed by five main sessions. | Behavioural | Psychoeducation-Based Motivational Interviewing |
Primary outcome
Schizophrenia Knowledge Level
Time frame: Baseline (pre-test) prior to the intervention, immediately after completion of the final intervention session (post-test), and 1 month after completion of the intervention (follow-up assessment).
Change in schizophrenia-related knowledge level assessed using the Schizophrenia Knowledge Level Scale. The scale consists of multiple-choice items assessing knowledge about schizophrenia, with total scores ranging from 0 to 25. Higher scores indicate greater knowledge about schizophrenia.
1 secondary outcome
Schizophrenia Hope Level
Time frame: Baseline (pre-test) prior to the intervention, immediately after completion of the final intervention session (post-test), and 1 month after completion of the intervention (follow-up assessment).
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Jan 2026.
- Individual participant dataSharing planned: No. Individual participant data will not be shared, as the study is conducted as part of a master's thesis and the data are collected solely for academic purposes. All data are kept confidential in accordance with ethical approval and institutional regulations.
Related trials for Schizophrenia
RecruitingPhase 3
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
Schizophrenia, Autism-Related Irritability
Not yet recruiting
Deep Brain Stimulation for Treatment-Resistant Schizophrenia
Treatment Resistant Disorders
Not yet recruitingObservational study
Sleep Monitoring for Early Detection of Relapse in People With Schizophrenia or Bipolar Disorder Receiving Usual Treatment
Bipolar Disorder (BD), SCHIZOPHRENIA 1 (Disorder)
Not yet recruitingPhase 1
Pharmacokinetics and Relative Bioavailability of Intranasal vs Intramuscular Olanzapine in Healthy Adult Participants
Healthy Adult Participants
Active, not recruiting
Designing and Evaluating a Classroom-Based Mental Health Programme for Adolescents.
Mental Health Promotion
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ceren Aycanoğlu, Assoc. Prof. Dr. principal investigator
Okan University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Psychoeducation-Based Motivational Interviewing in people with Schizophrenia, run by Büşra Taşkıner at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 26 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Schizophrenia Knowledge Level (time frame: Baseline (pre-test) prior to the intervention, immediately after completion of the final intervention session (post-test), and 1 month after completion of the intervention (follow-up assessment).). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jan 2026.